Burlington Stores vs Macy's
BURL and M side by side, both in general merchandise stores. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BURL and M compare
Burlington Stores is the larger company, worth 2.4 times as much as Macy's ($15.3B against $6.5B).
On earnings, Macy's is cheaper: it trades at 9.0× trailing earnings, against 21.8× for Burlington Stores.
Burlington Stores grew revenue faster over the last twelve months (10.9% versus 0.34% for Macy's).
Burlington Stores keeps more of each dollar of sales as profit, with a net margin of 5.8% compared with 3.3% at Macy's.
Macy's pays a dividend yielding 3.1%; Burlington Stores does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BURL | M |
|---|---|---|
| Size and price | ||
| Market cap | $15.3B | $6.5B |
| Share price | $242.86 | $24.70 |
| Change, 1 year | −15.4% | 20.0% |
| Change, 5 years | −8.3% | −28.8% |
| Beta (5Y) | 1.05 | 1.48 |
| Employees | 83K | 95K |
| StockData Score | ||
| Total score | 15 | 15 |
| Valuation score | 4 | 4 |
| Growth score | 4 (better) | 2 |
| Performance score | 4 (better) | 3 |
| Health score | 3 | 3 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 21.8× | 9.0× (better) |
| P/S | 1.2× | 0.3× (better) |
| P/B | 7.6× | 1.3× (better) |
| EV/EBITDA | 11.2× | 3.8× (better) |
| P/FCF | 37.0× | 4.6× (better) |
| PEG | 0.55 | – |
| FCF yield | 2.7% | 21.9% (better) |
| Fair value | $329.95 | $45.58 |
| Margin of safety | 26.4% | 45.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 10.9% (better) | 0.34% |
| Revenue growth, 5Y average | 14.9% (better) | 5.5% |
| Net income growth (TTM) | 30.7% | 51.5% (better) |
| EPS growth (TTM) | 31.6% | 56.6% (better) |
| Profitability | ||
| Gross margin | 44.6% (better) | 40.7% |
| Operating margin | – | 5.0% |
| Net margin | 5.8% (better) | 3.3% |
| FCF margin | 3.4% | 6.2% (better) |
| Return on equity | 41.4% (better) | 16.0% |
| Return on invested capital | – | 14.1% |
| Financial health | ||
| Debt / equity | 0.96 | 0.49 (better) |
| Net debt / EBITDA | 0.83 | 0.56 (better) |
| Current ratio | 1.17 | 1.59 (better) |
| Altman Z-score | 2.73 (better) | 2.23 |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 3.1% |
| Payout ratio | – | 26.4% |
| Years of dividend growth | – | 4 |
| Dividend growth, 5Y average | – | 14.1% |
| Buyback yield | 2.3% | 3.2% (better) |
| Shareholder yield | 2.3% | 6.2% (better) |
| Ownership | ||
| Held by institutions | 103% | 98.5% |
| Held by insiders | 0.63% | 0.39% |
| Insider net buying, 12 months | −$16.6M | −$6.7M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 4.7% | 13.5% |
Go deeper
- BURL stock overview
- BURL income statement
- BURL valuation and score
- M stock overview
- M income statement
- M valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.